Literature DB >> 16548691

Comparative analysis of methods for assessment of circulating endothelial progenitor cells.

Jacob George1, Haim Shmilovich, Varda Deutsch, Hylton Miller, Gad Keren, Arie Roth.   

Abstract

The number and properties of endothelial progenitor cells (EPC) in disease states is of considerable interest due to the importance attributed to this distinct cell population. However, there has been no study comparing each of the methods employed in the same sampled individuals. Herein, we performed an analysis of several methods used for circulating EPC assessment and correlated them with humoral factors known to influence their numbers. Thirty-eight individuals (mean age of 34 +/- 9 years) were tested. Peripheral blood mononuclear cells were obtained and stained for FACS analysis with antibodies to CD34, CD45, CD133, and KDR and the remaining cells grown under endothelial cell conditions for assessment of colony-forming unit (CFU) numbers and adhesive properties. Levels of circulating vascular endothelial growth factor (VEGF), erythropoietin (EPO), and C-reactive protein (CRP) were determined and correlated with each of the EPC markers. CFU numbers did not correlate with CD34/KDR or CD34/CD133/KDR and negatively correlated with CD34/ CD133 numbers. CD34/KDR numbers correlated with CD34/CD133/KDR, but not with CD34/ CD133. Only CD34/KDR and CD34/CD133/KDR correlated with VEGF serum levels. The number of EPC adhering to fibronectin and endothelial cells correlated with CFU numbers and not with either of the EPC membrane markers. Current methods for quantitatively assessing numbers of circulating EPC are not correlated. VEGF serum levels are associated only with CD34/KDR and CD34/ CD133/KDR, whereas CFU numbers correlate with EPC functional properties. These findings may suggest that CD34/KDR is more appropriate for the definition of circulating EPC, whereas CFU numbers are more likely to reflect their ability to proliferate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548691     DOI: 10.1089/ten.2006.12.331

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  37 in total

1.  Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome.

Authors:  Shmuel Schwartzenberg; Arnon Afek; Gideon Charach; Ardon Rubinstein; Yossi Ben-Shoshan; Sarina Kissil; Sofia Maisel-Auslender; Gad Keren; Jacob George
Journal:  World J Cardiol       Date:  2010-09-26

2.  Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.

Authors:  Carol Lin; Augustine Rajakumar; Daniel A Plymire; Vivek Verma; Nina Markovic; Carl A Hubel
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

3.  Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.

Authors:  Yoav Michowitz; Emil Goldstein; Dov Wexler; David Sheps; Gad Keren; Jacob George
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

4.  Isolation of cultured endothelial progenitor cells in vitro from PBMCs and CD133(+) enriched cells.

Authors:  Weihong Zheng; Yafeng Wan; Xiaopeng Ma; Xingrui Li; Zhifang Yang; Qian Yin; Jilin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

5.  Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix.

Authors:  Adinarayana Andukuri; Young-Doug Sohn; Chidinma P Anakwenze; Dong-Jin Lim; Brigitta C Brott; Young-Sup Yoon; Ho-Wook Jun
Journal:  Tissue Eng Part C Methods       Date:  2012-12-19       Impact factor: 3.056

6.  Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

Authors:  Yuyu Yao; Zulong Sheng; Yefei Li; Fengdi Yan; Cong Fu; Yongjun Li; Genshan Ma; Naifeng Liu; Julie Chao; Lee Chao
Journal:  Hum Gene Ther       Date:  2012-04-30       Impact factor: 5.695

7.  Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.

Authors:  Thomas J Povsic; Katherine L Zavodni; Enrikas Vainorius; Jennifer F Kherani; Pascal J Goldschmidt-Clermont; Eric D Peterson
Journal:  Am Heart J       Date:  2008-12-09       Impact factor: 4.749

8.  Circulating Endothelial Progenitor Cells: Potential Biomarkers for Idiopathic Dilated Cardiomyopathy.

Authors:  Santiago Roura; Carolina Gálvez-Montón; Marco A Fernández; Josep Lupón; Antoni Bayes-Genis
Journal:  J Cardiovasc Transl Res       Date:  2016-01-06       Impact factor: 4.132

9.  Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritis.

Authors:  Jacob N Ablin; Zacharinka Goldstein; Valerie Aloush; Hagit Matz; Ori Elkayam; Dan Caspi; Shmuel Swartzenberg; Jacob George; Yonit Wohl
Journal:  Rheumatol Int       Date:  2008-08-15       Impact factor: 2.631

10.  Circulating endothelial progenitor cells in cerebrovascular disease.

Authors:  Keun-Hwa Jung; Jae-Kyu Roh
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.